PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

摘要

The present invention relates to peptides, nucleic acids and cells for use in immunotherapy methods. In particular, the present invention relates to immunotherapy for cancer. The present invention is also a tumor-associated T for transfer to a patient by stimulating an anti-tumor immune response or stimulating T cells ex vivo, either alone or in combination with, for example, other tumor-associated peptides capable of serving as an active pharmaceutical component of a vaccine composition. It relates to cell epitopes. The peptide bound to the molecule of the major histocompatibility complex (MHC) or the peptide itself may be a target of antibodies, soluble T cell receptors, and other binding molecules.